Back

Transcriptional changes consistent with impaired neuronal differentiation, angiogenesis, and tumor plasticity induced in human subpallial telencephalic organoid-glioblastoma chimeras.

Chiola, S.; Yang, J.; Ullah, H. M. A.; Napan, K.; Huang, Q.; Gamboa, N.; Youssef, O.; Colman, H.; Cheshier, S.; Shcheglovitov, A.

2023-05-11 cancer biology
10.1101/2023.05.11.540229 bioRxiv
Show abstract

Glioblastoma multiforme (GBM) is one of the most aggressive and therapy-resistant brain tumors prevalent in both adults and children. Despite extensive research to understand GBM pathology, it remains unclear how neural cells in the human brain interact with GBM cells to support their brain propagation and therapy resistance and whether GBM cells exert any influence on the properties of human neural cells. In this study, we co-culture human stem cell-derived subpallial telencephalic organoids with patient-derived proneural or mesenchymal GBM spheroids to investigate their reciprocal interactions. We show that both proneural and mesenchymal GBM spheroids readily fuse and propagate with human organoids, forming organoid-GBM chimeras, without the need for exogenous growth factors. GBM cells within the chimeras adapt by modulating gene expression profiles consistent with diminished proliferation, heightened hypoxia, increased angiogenesis, and proneural-to-mesenchymal transition in proneural GBM. Both proneural or mesenchymal GBMs also exert an impact on the properties of neural cells in the chimeras, leading to the suppression of neuronal genes and an upregulation expression of genes associated with hypoxia and angiogenesis. Collectively, this study identifies specific genes and molecular pathways that can be altered in GBM and neural cells by reciprocal interactions in a human developing brain-like environment for an increased understanding of GBM pathology and future therapy development.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Neoplasia
22 papers in training set
Top 0.1%
10.9%
2
Scientific Reports
3102 papers in training set
Top 8%
8.8%
3
PLOS ONE
4510 papers in training set
Top 30%
5.1%
4
Neuro-Oncology
30 papers in training set
Top 0.2%
4.5%
5
Acta Neuropathologica Communications
81 papers in training set
Top 0.1%
4.1%
6
Neuro-Oncology Advances
24 papers in training set
Top 0.2%
3.4%
7
JCI Insight
241 papers in training set
Top 2%
3.0%
8
Cancers
200 papers in training set
Top 2%
2.5%
9
Cells
232 papers in training set
Top 1%
2.2%
10
iScience
1063 papers in training set
Top 9%
2.2%
11
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 3%
2.2%
12
Cancer Letters
32 papers in training set
Top 0.1%
2.0%
50% of probability mass above
13
eLife
5422 papers in training set
Top 37%
2.0%
14
Cell Reports
1338 papers in training set
Top 22%
1.9%
15
Neurobiology of Disease
134 papers in training set
Top 2%
1.7%
16
Cell Reports Medicine
140 papers in training set
Top 4%
1.5%
17
Biomolecules
95 papers in training set
Top 0.6%
1.5%
18
Journal of Neuroinflammation
50 papers in training set
Top 0.5%
1.4%
19
Cell Reports Methods
141 papers in training set
Top 3%
1.4%
20
Molecular Cancer
14 papers in training set
Top 0.5%
1.3%
21
Cell Death & Disease
126 papers in training set
Top 2%
1.0%
22
Advanced Science
249 papers in training set
Top 15%
1.0%
23
mSphere
281 papers in training set
Top 5%
1.0%
24
Glia
74 papers in training set
Top 0.4%
0.8%
25
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
26
Epigenetics
43 papers in training set
Top 0.8%
0.8%
27
npj Precision Oncology
48 papers in training set
Top 1%
0.8%
28
Cancer Research
116 papers in training set
Top 3%
0.8%
29
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
30
Communications Biology
886 papers in training set
Top 22%
0.8%